Pieris Pharmaceuticals, Inc.
PIRS
Revenue
0.00
▼-53.00k▼-100.00%
3 Months ChangeAssets
25.05M
▼-4.45M▼-15.07%
3 Months ChangeLiabilities
11.92M
▼-16.94M▼-58.70%
3 Months ChangeFree Cash Flow
-7.00M
▲4.05M▲36.65%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-03
Form 8-K
ID: 0001437749-24-030559
2024-08-14
Form 10-Q
ID: 0001437749-24-026778
2024-08-08
Form 8-K
ID: 0001437749-24-025565
2024-07-24
Form 8-K
ID: 0001437749-24-023301
2024-07-03
Form 8-K
ID: 0001437749-24-022188
2024-05-15
Form 10-Q
ID: 0001437749-24-017037
2024-05-09
Form 8-K
ID: 0001437749-24-015466
2024-04-18
Form 8-K
ID: 0001437749-24-012442
2024-03-27
Form 8-K
ID: 0001437749-24-009491
2023-12-21
Form 8-K
ID: 0001437749-23-035107